September 29, 2020 -Study also Demonstrates that MolecuLight Fluorescence Imaging of Bacteria at Point-of-Care Resulted in Changes to Treatment Planning in 69% of All Patient Cases
Toronto, CANADA – (September 29, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announced publication of results from the
… Read More
August 12, 2020 -MolecuLight i:X’s fluorescence images and digital measurements of patient wounds can now be saved and viewed in Epic
Toronto, CANADA – (August 12, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform on the… Read More
July 9, 2020 -New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards
Toronto, CANADA – (July 9, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the
… Read More
June 15, 2020 -Leading GPO Accepts MolecuLight i:X Point-of-Care Device for Detection of Bacteria and Digital Wound Measurement for its National Membership
Toronto, CANADA – (June 15, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform to
… Read More
June 11, 2020 -New Code Enables Facility Reimbursement to Hospital Outpatient Centers Performing MolecuLight’s Procedure Benefiting Wound Care Patients
Toronto, CANADA – (June 11, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has
… Read More
April 1, 2020 -Novel Virtual Conference Attracts 10,000 Wound Care Professionals as Alternate to Live Medical Conferences Given Travel Challenges Due to Covid-19
Toronto, CANADA and Atlantic Beach, USA – (April 1, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation
… Read More
March 3, 2020 -In Vitro Study Demonstrates Detectable Red Fluorescence from 88% of Planktonic and Biofilm Wound Pathogens when Imaged by the MolecuLight i:X® Imaging Device
Toronto, CANADA – (March 3, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of “… Read More
February 20, 2020 -i:X Platform’s Precise Wound Measurement, along with Fluorescence Imaging, for More Accurate Detection and Ongoing Documentation of Wounds
Toronto, CANADA – (February 20, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, released a significant upgrade to its i:X digital wound measurement
… Read More
February 13, 2020 -
Reimbursement Pathway Established for MolecuLight’s i:X Procedure in Wound Care
TORONTO, Canada – (February 13, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announced that the American Medical Association (AMA) has issued two new CPT category lll codes to enable a
… Read More